Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2006 June;31(2) > Minerva Endocrinologica 2006 June;31(2):125-31

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

  CLINICAL ADVANCES IN DIABETES MELLITUS 

Minerva Endocrinologica 2006 June;31(2):125-31

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

The clinical utility of leptin therapy in metabolic dysfunction

Park J. Y., Gavrilova O., Gorden P.

National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Bethesda, MD, USA


PDF


Obesity and diabetes are major public health threats worldwide. Insulin resistance appears to be a significant factor in this global epidemic. In this present review, we have focused on a human model of insulin resistance which embodies many of the metabolic abnormalities that are associated with the morbidity of diabetes and obesity. Lipodystrophy in rodents and humans is a severe model of insulin resistance, and we use a novel therapeutic approach with the administration of the newly discovered leptin to ameliorate many of these metabolic abnormalities. The ability to study the administration of leptin in this setting of severe insulin resistance allows us perform a coveted look into a human condition where metabolic dysfunction can be reversed or controlled.

top of page